APA (7th ed.) Citation

JR, H., IA, v. Z., DA, C., T, P., SK, K., G, S., . . . G, H. (2023). Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood cancer journal, 13(1), 93. https://doi.org/10.1038/s41408-023-00850-6

Chicago Style (17th ed.) Citation

JR, Hilberink, et al. "Age and Sex Associate with Outcome in Older AML and High Risk MDS Patients Treated with 10-day Decitabine." Blood Cancer Journal 13, no. 1 (2023): 93. https://doi.org/10.1038/s41408-023-00850-6.

MLA (9th ed.) Citation

JR, Hilberink, et al. "Age and Sex Associate with Outcome in Older AML and High Risk MDS Patients Treated with 10-day Decitabine." Blood Cancer Journal, vol. 13, no. 1, 2023, p. 93, https://doi.org/10.1038/s41408-023-00850-6.